Is there a correlation between OSAS duration/severity and carotid intima-media thickness?  by Ciccone, Marco Matteo et al.
Respiratory Medicine (2012) 106, 740e746Available online at www.sciencedirect.com
journal homepage: www.elsevier .com/locate /rmedIs there a correlation between OSAS duration/
severity and carotid intima-media thickness?Marco Matteo Ciccone a,*, Pietro Scicchitano a, Gianfranco Mitacchione a,
Annapaola Zito a, Michele Gesualdo a, Paola Caputo a,
Mario Francesco Damiani b, Marco Sassara a, Stefano Favale a,
Onofrio Resta b, Pierluigi Carratu` ba Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation, University of Bari,
School of Medicine, Policlinico, Piazza Giulio Cesare, 70124 Bari, Italy
bDepartment of Pneumology, University of Bari, School of Medicine, Policlinico, Piazza Giulio Cesare, 70124 Bari, Italy
Received 28 July 2011; accepted 21 December 2011
Available online 7 February 2012KEYWORDS
Obstructive sleep
apnea syndrome;
OSAS;
IMT;
Cardiovascular risk* Corresponding author. Piazza G. C
E-mail address: ciccone@cardio.un
0954-6111/$ - see front matter ª 201
doi:10.1016/j.rmed.2011.12.016Summary
Background: Obstructive Sleep Apnea Syndrome (OSAS) is a common airways disease recog-
nized as an independent cardiovascular risk factor. It is often associated with obesity, dia-
betes and dyslipidemia. Its pathophysiological consequences (hypoxia, hypercapnia,
micro-arousals, sympathetic hyperactivity, oxidative stress, systemic inflammation and
hyper-coagulability) are implicated in the development of hypertension, endothelial
dysfunction and higher intima-media thickness (IMT) values, all elements known to lead
to atherosclerosis. The study aim was to demonstrate a relationship between OSAS dura-
tion and IMT values and to confirm how OSAS severity could influence IMT (a marker of
atherosclerosis).
Methods: We enrolled 156 patients (125 men, mean age: 60  12 years) affected by OSAS of
different severity: 111 (71%) were in CPAP therapy; some of the population were also
affected by hypertension [102 (65%)], dyslipidemia [52 (33%)] and diabetes [38 (24%)].
Patients underwent evaluation of carotid artery IMT and answered a questionnaire investi-
gating the time of onset (confirmed by a person aware of the patient’s previous sleeping
habits) and the duration of the disease.
Results: We found a statistically significant higher IMT value in patients with longer-lasting
disease (OSAS duration in IMT < 0.9 mm: 120 (60e192) months versus OSAS duration in
IMT  0.9 mm: 200 (120e310) months; p < 0.001). OSAS severity is positively related to
IMT values. We found a positive relationship between IMT and OSAS duration [r Z 0.34;
p < 0.001] and between AHI and IMT [r Z 0.51; p < 0.001].esare 11, 70124 Bari Italy. Tel.: þ39 080 5478791; fax: þ39 080 5478796.
iba.it (M.M. Ciccone).
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Obstructive Sleep Apnea Syndrome (OSAS) is a highly
prevalent pneumological disease,1 considered to be
numbered among cardiovascular risk factors, together with
hypertension,1 obesity, diabetes and dyslipidemia.2 By
definition, apneic and hypopneic events last a minimum of
10 s. For a diagnosis of OSAS to be made, at least 5 apnea
events must occur per hour of sleep time in association with
clinical symptoms, or at least 15 apnea events must occur
per hour of sleep time with or without clinical symptoms.3
For this reason, OSAS is characterized by increased respi-
ratory effort, intermittent arterial oxygen desaturation,
systemic and pulmonary arterial blood pressure surges and
sleep dysruption. The main symptoms of OSAS are nocturnal
respiratory pauses interrupted by loud intermittent snoring
and excessive daytime somnolence.4 OSAS has been shown
to be an important independent cardiovascular risk
factor,1,5,6 although the precise mechanism underlying the
link between OSAS and cardiovascular diseases still has not
been fully explained.
Important studies have demonstrated an independent
relationship between OSAS and cardiovascular disease.7
Various different mechanisms are involved in the patho-
genesis of cardiovascular disorders in OSAS patients. Apnea-
induced hypoxia, hypercapnia, micro-arousals, sympathetic
hyperactivity, oxidative stress, systemic inflammation,8
hyper-coagulability,9 are all mechanisms that play
a central role in the development of endothelial dysfunc-
tion,5 increasing arterial blood pressure10 and carotid
artery intima-media thickness (IMT).11 There is
evidence12,13 that OSAS is related to insulin resistance and
impaired glucose tolerance, well-known to be elements
underlying processes of disorganization of the vessel
structures. All these factors induce endothelial dysfunction
but, if detected early, it may be possible to slow the
progression of the atherosclerotic disease, by treating the
underlying illness.
Many studies have investigated the correlation between
OSAS severity and carotid IMT measurements, a parameter
considered as an index of endothelial alterations, and have
demonstrated that a more severe degree of OSAS is related
to an elevated risk of atherosclerotic disease.6 OSAS
patients complain of complex symptoms (daytime hyper-
somnolence, headache on awakening, snoring, restless
sleep, several micro-arousals, perception of apnea during
the night, enuresis, sexual impotence). For this reason,
patients are encouraged to undergo a poly-somnographic
study.
In common clinical experience, there is a considerable
delay between the diagnosis of OSAS and the true onset of
the syndrome: several months or years may pass from the
beginning of symptoms to the beginning of therapy,
exposing the patient to the negative cardiovascular effects
of the disease for a longer time.The aim of our study was to investigate the relationship
between the duration of OSAS, since the beginning of
symptoms, and IMT values, to see whether there is
a correlation between endothelial alterations and the
duration of OSAS itself. We would like to confirm the rela-
tionship between OSAS severity and IMT values of the same
patients.Materials and methods
Population
The study was conducted in 156 patients (125 M; 31 F) aged
60  11 years with a diagnosis of OSAS of different degrees
of severity; 111 (71%) were in CPAP therapy and some of the
population were also affected by hypertension [102 (65%)],
dyslipidemia [52 (33%)] and diabetes [38 (24%)], although
all the latter patients were in optimal pharmacological
treatment (anti-hypertensive drugs, statins, oral hypogly-
cemic agents) for their cardiovascular risk factors (see
Table 1 for more details). The study was approved by the
Institutional Review Board of Bari University General
Hospital and carried out in accordance with the principles
of the Helsinki Declaration. All patients gave prior written
informed consent to take part in the study.
The patients had had a clinical diagnosis of OSAS at
different times. The clinical history was closely investi-
gated, and a physical examination, electrocardiography,
ambulatory blood pressure monitoring, echocardiography,
and ultrasound examination of the carotid arteries were
performed in all patients.
Particular attention was paid to inquiring into the true
timing of the onset of OSAS symptoms, by means of
a questionnaire14 submitted to each patient and to another
person known to be aware of the patient’s previous
sleeping habits (wife, husband, partner, mother, father).
The questionnaire had been already validated14 and could
be considered as a modified version of the Sleep and
Healthy questionnaire,15 although accompanied with
a trained interviewer and the partners’ presence in order to
reduce bias caused by the questionnaire solely filled out by
the same patient. We focused on important clinical symp-
toms in OSAS (daytime hyper-somnolence, headache on
awakening, snoring, restless sleep, several micro-arousals,
perception of apnea during the night, enuresis, sexual
impotence), asking the patient and his/her relatives to
grade them from 1 to 5 (1: very mild, 2: mild, 3: moderate,
4 severe, 5 very severe), and inquiring particularly into the
date of onset of these symptoms in order to calculate the
duration of the period of OSAS of the patients. Apart from
personal data and the questionnaire, a careful medical
history was taken, including close questions about the use
of CPAP therapy (beginning date; how many times a week it
was used, i.e. every time during sleep, every night,
Table 1 General characteristics of patients according to IMT values.
Total N Z 156 IMT < 0.90 N Z 85 IMT  0.90 N Z 71 p
Age (years) 60  12 56  11 64  11 <0.001
Male N. 125 (80) 69 (81) 56 (79) 0.72
SBP mm/Hg 127  13 124  12 130  14 0.002
DBP mm/Hg 83  9 83  8 83  10 0.62
Hypertension 102 (65) 49 (58) 53 (75) 0.026
Diabetes 38 (24) 17 (20) 21 (30) 0.17
Dyslipidemia 52 (33) 25 (29) 27 (38) 0.26
Previous myocardial ischemia 20 (13) 6 (7) 14 (20) 0.019
Months since the beginning of OSAS symptoms 156 (96e240) 120 (60e192) 200 (120e310) <0.001
Months of CPAP therapy 24 (1e72) 12 (1e84) 42 (1e72) 0.66
Current symptoms 81 (52) 42 (49) 39 (55) 0.49
BMI 34  7 34  7 34  8 0.94
AHI 28 (18e43) 20 (14e28) 41 (32e58) <0.001
OSAS mild (AHI 5e15) 27 (17) 27 (32) 0 (0) <0.001
OSAS moderate (AHI 16e30) 56 (36) 40 (47) 16 (23) 0.0015
OSAS severe (AHI 31e60) 57 (37) 16 (19) 41 (58) <0.001
OSAS very severe (AHI>60) 16 (10) 2 (2) 14 (20) 0.0004
Smokers 31 (20) 17 (20) 14 (20) 0.9650
N. cigarettes/die 20  10 18  10 22  10 0.2954
Mean IMT 0.83  0.15 0.73  0.09 0.95  0.1
Data are presented as mean values  SD, median (interquartile range), or as number and percentage. SBP: systolic blood pressure, DBP:
diastolic blood pressure, OSAS: obstructive sleep apnea syndrome, CPAP: continuous positive airway pressure, BMI: body mass index,
AHI: apnea-hypopnea index, IMT: intima-media thickness.
Figure 1 Pearson correlation analysis between the IMT value
and years since the onset of symptoms.
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a week, once or twice times a week, never).
In some cases, the exact moment in which the OSAS
symptoms began could have been clustered by patients in
10 or 20 years due to memory deficit of patients. During our
interview, we tried to overcome such a bias trying to
understand if patients approximation was right, considering
relatives’ declaration and comparing the news coming from
the latters to those coming from the patients, in order to
reduce the gap between the correct data of symptoms
beginning and the answers of the patients. This could be
considered as a limitation of the study although in a wide
group of patients like the one considered it could be
understandable to identify such a reduced perfection level
of the research due to variability in population members.
For this reason we gathered such an issue in Fig. 1 which
pictured the variability of our population’s declarations.
No group control without OSAS had been considered
because the main aim of our research was to assess the
relationship between OSAS duration and IMT values. In such
a vision, we consider useless a group control composed by
patients not suffering from OSAS, because it would go
beyond any hypothesis of our research.
Obstructive sleep apnea syndrome (OSAS) diagnosis
OSAS was diagnosed after a 1-night in-hospital sleep study.
Patients’ body movements, heart and pulse transit time
(PTT) changes were recorded as measures of arousal from
sleep. Pulse oximetry was recorded. The results of the
sleep study were scored automatically, and subsequently
reviewed to ensure accuracy of the data. OSAS was diag-
nosed from a review of all data and the severity wasquantified as the number of oxygen desaturations by more
than 4% per hour of study (ODI).
The OSAS diagnosis was made on the basis of an apnea/
hypopnea index (AHI)  5.
IMT carotid ultrasonography
All patients underwent two-dimensional echo-color Doppler
of the carotid arteries, adopting a high definition vascular
echograph Philips Sonos 5500 Bothell, Washington, USA and
a 10-3 MHz linear electronic probe. All the examinations
were performed by the same physician in order to reduce
bias. During the procedure, patients were placed in supine
OSAS duration/onset and carotid IMT 743position, with the neck extended and turned con-
tralaterally by about 45. The IMT was defined as the
distance between the lumen-intima and media-adventitia
borders of the vessel, ultrasonographically identified by
a double hypoechoic line not projecting into the vessel
lumen.16,17
Firstly, we explored the carotid arteries bilaterally to
exclude the possible presence of atherosclerotic plaque;
then we calculated the intima-media thickness of the
distal wall of the right common carotid artery on the
lengthwise axis, according to the method described by
Pignoli et al.18
Echo-measurements were made in three zones:
 Proximal zone: about 2 cm above the flow-divider;
 Distal zone: about ½ cm above the flow-divider;
 Middle zone.
These data were used to obtain the arithmetical mean
IMT value (m-IMT).Statistical analysis
Data are presented as mean  SD unless otherwise indi-
cated. Differences between groups were analyzed by t test
for independent samples. Coefficients of correlation were
calculated between continuous variables by the Pearson
correlation analysis. Multiple regression analysis was per-
formed including variables associated with IMT at univar-
iate analysis. Categorical variables were compared
between groups by means of c2 test. A value of p < 0.05
was considered statistically significant. The analyses were
made using STATISTICA 6.1 software (StatSoft Inc., Tulsa,
Oklahoma).Table 2 Correlation between IMT with continuous
parameters.
R P
Age (years) 0.395 <0.001
SBP mm/Hg 0.209 0.01
DBP mm/Hg 0.107 0.183
Months since the beginning
of OSAS symptoms
0.342 <0.001
BMI 0.043 0.597
AHI 0.508 <0.001
Data are presented as mean values  SD or as number and
percentage. IMT: intima-media thickness, SBP: systolic blood
pressure, DBP: diastolic blood pressure, OSAS: obstructive sleep
apnea syndrome, BMI: body mass index, AHI: apnea-hypopnea
index, r: Pearson’s correlation coefficient.Results
Characteristics of the population study, subdivided
according to IMT values, are shown in Table 1.
According to European Society of Cardiology (ESC)
statements, a common carotid artery IMT > 0.9 mm can be
considered as a conservative estimate of existing abnor-
malities.19 There are significant differences (p < 0.001) in
terms of population age, number of months with OSAS
symptoms and the AHI index, according to the IMT. Patients
with an IMT  0.9 mm were older, had a longer duration of
OSAS symptoms, and a higher AHI index value than patients
with an IMT < 0.9 mm.
Patients with an IMT  0.9 mm were more frequently in
treatment for hypertension than those with an
IMT < 0.9 mm, this difference being statistically significant
(p Z 0.026). Patients with altered IMT values also had
a significantly (p Z 0.002) higher mean value of SBP than
patients with normal IMT values.
In patients with IMT values <0.9 mm, there was
a significant proportion of patients affected by low
(p < 0.001) and moderate (p Z 0.0015) forms of OSAS;
instead, a significant number of patients with IMT val-
ues  0.9 mm were affected by severe (p < 0.001) and very
severe (p Z 0.0004) forms of OSAS.A significantly (p Z 0.019) higher number of patients
with ischemic diseases presented an IMT value  0.9 mm. A
significant presence (p Z 0.031) of Stasis dermatitis was
present in patients with a skewed IMT.
In Table 2 we have analyzed only continuous variables
according to the IMT. The Pearson correlation coefficient
underlined the fact that age, the number of months with
OSAS symptoms and the AHI index results positively and
strongly correlated with higher IMT values (p < 0.001). Figs.
1 and 2 depict the relationship between IMT values and the
number of months with OSAS symptoms/AHI in our pop-
ulation. In particular, they showed a positive relationship
between IMT and OSAS duration [r Z 0.34; p < 0.001] and
between AHI (index of OSAS severity) and IMT [r Z 0.51;
p < 0.001], although such coefficients of correlation
showed a low-moderate relationship.
On this basis, Table 3 shows the multivariate predictors
of IMT to calculate the influence of age, the number of
months with OSAS symptoms and the AHI index, taken
singly, on the IMT.
On the basis of our data, IMT at multivariate analysis was
significantly predictive by age ( 10; 1 SD), months of
symptoms duration ( 10; 1 SD) and AHI ( 10; 1 SD).Discussion
Obstructive sleep apnea is characterized by repetitive
episodes of complete (apnea) or partial (hypopnea) upper
airways obstruction occurring during sleep.
It seems to be an important cardiovascular risk
factor,1,5,6 whose pathogenesis is still unexplained.
Many hypotheses4,20,21 have been proposed: first of all,
oxidative stress seems to be one of the first causes of
endothelial impairment in OSAS patients. Hypoxia is a part
of the natural history of the illness and causes real
damage to the endothelium. Besides, OSAS leads to
sympathetic nervous system overactivity, a condition that
can induce early alterations in the vascular morphology
leading towards the atherosclerotic process. OSAS12,13 is
related to insulin resistance and impaired glucose toler-
ance and the consequence is the induction of endothelial
dysfunction.
Figure 2 Pearson correlation analysis between the IMT value
and the AHI value.
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vascular structures leading towards a systemic atheroscle-
rotic process is the IMT evaluation. Literature data22
suggest that intima-media thickness is an expression of
early alterations in vascular morphology: this is not synon-
ymous with atherosclerosis but because the underlying
pathophysiological mechanisms are similar, the two condi-
tions have been associated since Pignoli’s work18 pointed
this out.
In an important study by Protogerou et al.,23 the authors
analyzed vascular impairment induced by several different
degrees of OSAS. They underlined how the IMT worsens as
the syndrome degenerates, and our results seem to
underline this aspect. In fact, as shown in Table 1, OSAS is
able to increase the IMT value. IMT values  0.9 mm were
significantly more frequently present in patients with all
degrees of OSAS than IMT values <0.9 mm (p < 0.001). This
has strong implications not only in view of the risk of
cardiovascular disease but even of later cerebrovascular
events, as many literature data24 confirm.
It is important to note that our population is fairly
homogeneous as regards the influence of several cardio-
vascular risk factors that may affect the results. Diabetes,
dyslipidemia, BMI at the time of diagnosis of OSAS and
during the evaluation time, number of smokers and ciga-
rettes smoked per day, are all parameters that could
influence the IMT, and in our population these elements are
well matched between people with IMT values of less or
more than 0.9 mm. Instead, age and hypertension, and
above all systolic blood pressure (SBP), seem to differen-
tiate our study group into two populations, and multiple
regression analyses confirm the data shown in Table 1.Table 3 Multivariate predictors of carotid intima-media thickn
Model 2 (R2 Z 0.40, p < 0.001) Model for 1 unit increase Mo
Age 0.00347  0.00091 0.
Symptoms duration 0.00023  0.00007 0.
AHI 0.00335  0.00048 0.
Beta coefficient  standard error. AHI: apnea-hypopnea index, SD: stHowever, since the aim of our work was to evaluate to what
extent the duration of OSAS could increase the vascular
risk, it is possible that the influence of age could be related
in parallel to the duration of the syndrome. Continuous
Positive Airways Pressure (CPAP) therapy could be another
limitation. Chung et al.25 demonstrated the influence of
CPAP therapy on improvements in OSAS patients risk
profiles, possibly related to the drug-induced reduction in
hypoxia and vascular inflammation. In our population, 111
(71%) patients were in CPAP therapy, and they were equally
distributed between patients with IMT values <0.9 mm and
0.9 mm (p Z 0.87). The months of treatment and
adherence to CPAP therapy were also similar between the
two groups (p Z 0.66 and p Z 0.18, respectively). In view
of these results, we do not consider CPAP therapy as
a source of bias.
The most important finding in our work is the strong
relationship between the months since the beginning of
OSAS symptoms and the severity of the cardiovascular risk
profile assessed on the IMT value. Notably, although it was
impossible to pinpoint the exact time of diagnosis of OSAS,
a mean interval of 156 (96e240) months elapsed between
the start of symptoms and the definite diagnosis of the
syndrome. There were significant differences between the
two groups (IMT < and 0.9 mm) in this respect [120
(60e192) vs 200 (120e310); p < 0.001], as shown in Table 1.
Disease duration is concentrated beyond 10 years and
96e240 is the interquartile range in which we could find the
majority of the population of the two groups.
To the best of our knowledge, no significant data like
these have previously been reported in the international
literature. Roisman et al.26 and Pelletier-Fleury et al.27
underline the need of a clear diagnosis in relation to the
heavy social, health and economic burden of OSAS on the
community. Surprisingly, a recent study by Kobayashi
et al.,28 points out that elderly onset OSAS patients have
milder symptoms than patients with middle-age onset. The
authors suggest that this result is due to a milder physio-
logical response to respiratory events. However, they do
not consider that patients in the middle-age onset group
have a longer disease duration, thus introducing a con-
founding factor. Despite the Kobayashi findings, multiple
regression analysis clearly shows in our study that age
influences the atherosclerosis process, and, if associated
with OSAS, the relationship could be even worse. Besides,
as literature data underline,29 OSAS is often a delayed
diagnosis and this situation could have a very negative
effect on the cardiovascular risk profile of patients, as re-
ported by Baguet et al.30 and confirmed in this work.
Indeed, we found a natural correlation between IMT and
the severity of OSAS as evaluated by the AHI: worsening of
the syndrome leads to a deterioration of the vascularess.
del for 10 unit increase Model for 1 SD increase P
0347  0.0091 0.040  0.011 <0.001
0023  0.0007 0.033  0.010 0.002
0335  0.0048 0.070  0.010 <0.001
andard deviation.
OSAS duration/onset and carotid IMT 745structures and increasing IMT values (rZ 0.51; p < 0.001).
The correlation is positive and linear: the higher the AHI the
higher the IMT. Moreover, as reported in literature,31,32
worsening of OSAS is clearly related to an increased
cardiovascular risk, in terms of both alterations of endo-
thelial function and other cardiovascular risk factors such
as weight gain.
Conclusions
Our work points out that the duration of OSAS is an
important element to be considered in the general
management of OSAS patients. It correlates with higher
values of IMT and hence with an elevated atherosclerosis
risk in these patients, underlining the importance of early
diagnosis of the disease in order to slow progression. OSAS
plays a role in the development of heart disease, shown to
be directly proportional, and strictly connected not only to
the severity of the form, but also to the duration.
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